Jul 08, 2026
For decades, prescribing medicine has followed a "one-size-fits-all" playbook: a standard drug, a standard dose, and a hopeful wait to see how the patient responds. The pharmacogenomic testing service is quietly dismantling that model. By reading the genetic variants that govern how an individual absorbs, metaboliz...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper